Home
>
US Stocks
>
Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals Inc
MIRM

Mirum Pharmaceuticals Inc (MIRM)

$15.70.96%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$15.01
Today Low/High
$15.01 / $15.77
52 Week Low/High
$13.85 / $26.99
Market Cap
$439.12M

Company Details

Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Mirum's lead product candidate, maralixibat, is an investigational oral drug in development for Alagille syndrome (ALGS), progressive familial intrahepatic cholestasis (PFIC), and biliary atresia. Mirum has submitted an NDA for maralixibat in the treatment of cholestatic pruritus in patients with ALGS. Additionally, Mirum's marketing authorization application for the treatment of pediatric patients with PFIC2 has been accepted for review (validated) by the European Medicines Agency.
Organisation
Mirum Pharmaceuticals Inc
Employees
68
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Mirum Pharmaceuticals Inc (MIRM) share price today?

Can Indians buy Mirum Pharmaceuticals Inc (MIRM) shares?

How can I buy Mirum Pharmaceuticals Inc (MIRM) shares from India?

Can Fractional shares of Mirum Pharmaceuticals Inc (MIRM) be purchased?

What are the documents required to start investing in Mirum Pharmaceuticals Inc (MIRM) stocks?

We are a SEBI registered investement advisor